Related Articles
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation
ENZYME, WHOLE CELL AND INVIVO TUMOR-MODELS TO IDENTIFY AND ASSESS INHIBITORS OF PP60(C-SRC)
Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression